NCT02780310View on ClinicalTrials.gov

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Adenoid Cystic Carcinoma
Interventions
DRUG

Lenvatinib

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

Unknown

Memorial Sloan Kettering Cancer Center, Basking Ridge

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre

07748

Memorial Sloan Kettering Monmouth, Middletown

All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER